[
  {
    "ts": null,
    "headline": "BioNTech Announces Settlement With National Institutes of Health, University of Pennsylvania Over Royalty Claims",
    "summary": "BioNTech (BNTX) on Friday announced separate agreements with the US National Institutes of Health an",
    "url": "https://finnhub.io/api/news?id=ec99ebaa846b49c01c78dfcb7de3359701bff04fbc3ef89b3b199a37e6686c4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735319490,
      "headline": "BioNTech Announces Settlement With National Institutes of Health, University of Pennsylvania Over Royalty Claims",
      "id": 132177907,
      "image": "https://media.zenfs.com/en/mt_newswires_premium_news_706/74e230b8992662f226078c750ea4e12a",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "BioNTech (BNTX) on Friday announced separate agreements with the US National Institutes of Health an",
      "url": "https://finnhub.io/api/news?id=ec99ebaa846b49c01c78dfcb7de3359701bff04fbc3ef89b3b199a37e6686c4a"
    }
  },
  {
    "ts": null,
    "headline": "Duvakitug And Teva's Growth: A Game Changer In Pharma",
    "summary": "Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here to find out why TEVA is a Buy.",
    "url": "https://finnhub.io/api/news?id=f932524cce0ab7e6732fb2bdfb867eccfcc2050d50d49631a3b1c7b1033d3814",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735312889,
      "headline": "Duvakitug And Teva's Growth: A Game Changer In Pharma",
      "id": 132178012,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1816401471/image_1816401471.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here to find out why TEVA is a Buy.",
      "url": "https://finnhub.io/api/news?id=f932524cce0ab7e6732fb2bdfb867eccfcc2050d50d49631a3b1c7b1033d3814"
    }
  },
  {
    "ts": null,
    "headline": "BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties",
    "summary": "The German company, which partners with U.S. drugmaker Pfizer for its COVID-19 vaccine, said on Friday it would pay $791.5 million to the U.S. agency to resolve a default notice.  Separately, the company will pay $467 million to the University of Pennsylvania (Penn), which has agreed to dismiss a lawsuit brought against the vaccine maker accusing it of underpaying royalties.",
    "url": "https://finnhub.io/api/news?id=c5b14a5a0fa6497a42e8f17300b99420f6af663de290d12d38eb3a2aba6268cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735304013,
      "headline": "BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties",
      "id": 132175367,
      "image": "https://media.zenfs.com/en/reuters.com/5eb866174a8e34b9ac245ec776b2cb5f",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The German company, which partners with U.S. drugmaker Pfizer for its COVID-19 vaccine, said on Friday it would pay $791.5 million to the U.S. agency to resolve a default notice.  Separately, the company will pay $467 million to the University of Pennsylvania (Penn), which has agreed to dismiss a lawsuit brought against the vaccine maker accusing it of underpaying royalties.",
      "url": "https://finnhub.io/api/news?id=c5b14a5a0fa6497a42e8f17300b99420f6af663de290d12d38eb3a2aba6268cf"
    }
  }
]